diabetes

You have accessRestricted Access
Mineralocorticoid Receptor Antagonists for Diabetic Kidney Disease
Peter Rossing

CJASN November 2020, CJN.16201020; DOI: https://doi.org/10.2215/CJN.16201020

Add to Selected Citations
You have accessRestricted Access
Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m²
George Bakris, Megumi Oshima, Kenneth W. Mahaffey, Rajiv Agarwal, Christopher P. Cannon, George Capuano, David M. Charytan, Dick de Zeeuw, Robert Edwards, Tom Greene, Hiddo J.L. Heerspink, Adeera Levin, Bruce Neal, Richard Oh, Carol Pollock, Norman Rosenthal, David C. Wheeler, Hong Zhang, Bernard Zinman, Meg J. Jardine and Vlado Perkovic

CJASN November 2020, CJN.10140620; DOI: https://doi.org/10.2215/CJN.10140620

Add to Selected Citations
Open Access
Acute Kidney Injury in a National Cohort of Hospitalized US Veterans with COVID-19
Benjamin Bowe, Miao Cai, Yan Xie, Andrew K. Gibson, Geetha Maddukuri and Ziyad Al-Aly

CJASN November 2020, CJN.09610620; DOI: https://doi.org/10.2215/CJN.09610620

Add to Selected Citations
You have accessRestricted Access
Metabolic Disorders with Kidney Transplant
Elizabeth Cohen, Maria Korah, Glenda Callender, Renata Belfort de Aguiar and Danielle Haakinson

CJASN May 2020, 15 (5) 732-742; DOI: https://doi.org/10.2215/CJN.09310819

Add to Selected Citations
Open Access
Sodium Glucose Cotransporter 2 Inhibition Heralds a Call-to-Action for Diabetic Kidney Disease
Katherine R. Tuttle, David Z. Cherney and on behalf of the Diabetic Kidney Disease Task Force of the American Society of Nephrology

CJASN February 2020, 15 (2) 285-288; DOI: https://doi.org/10.2215/CJN.07730719

Add to Selected Citations
Open Access
How Does CREDENCE Inform Best Use of SGLT2 Inhibitors in CKD?
Joshua J. Neumiller and Rita R. Kalyani

CJASN November 2019, 14 (11) 1667-1669; DOI: https://doi.org/10.2215/CJN.05340419

Add to Selected Citations
Open Access
Efficacy and Safety of Imarikiren in Patients with Type 2 Diabetes and Microalbuminuria
Sadayoshi Ito, Tomoya Kagawa, Takuya Saiki, Kohei Shimizu, Shingo Kuroda, Yuhei Sano and Yuusuke Umeda

CJASN March 2019, 14 (3) 354-363; DOI: https://doi.org/10.2215/CJN.07720618

Add to Selected Citations
You have accessRestricted Access
End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy
Joy Chieh-Yu Chen, Bjorg Thorsteinsdottir, Lisa E. Vaughan, Molly A. Feely, Robert C. Albright, Macaulay Onuigbo, Suzanne M. Norby, Christy L. Gossett, Margaret M. D’Uscio, Amy W. Williams, John J. Dillon and LaTonya J. Hickson

CJASN August 2018, 13 (8) 1172-1179; DOI: https://doi.org/10.2215/CJN.00590118

Add to Selected Citations
You have accessRestricted Access
Incidence and Progression of Chronic Kidney Disease in Black and White Individuals with Type 2 Diabetes
Claire Gerber, Xuan Cai, Jungwha Lee, Timothy Craven, Julia Scialla, Nao Souma, Anand Srivastava, Rupal Mehta, Amanda Paluch, Alexander Hodakowski, Rebecca Frazier, Mercedes R. Carnethon, Myles Selig Wolf and Tamara Isakova

CJASN June 2018, 13 (6) 884-892; DOI: https://doi.org/10.2215/CJN.11871017

Add to Selected Citations
You have accessRestricted Access
Time-Centered Approach to Understanding Risk Factors for the Progression of CKD
Elaine Ku, Kirsten L. Johansen and Charles E. McCulloch

CJASN May 2018, 13 (5) 693-701; DOI: https://doi.org/10.2215/CJN.10360917

Add to Selected Citations

Main menu

User menu

Search

diabetes

Pages

Articles

Information for Authors

About

Journal Information

More Information